Medical news
-
New gene therapy CME program launched
The World Federation of Hemophilia (WFH) is proud to announce the launch of Clinical Advances in Gene Therapy for Hemophilia, an online continuing medical education...
-
VWD Guidelines development—add your voice
As recently announced, the World Federation of Hemophilia (WFH) has joined a collaboration led by the American Society of Hematology (ASH), which also includes the...
-
ASH WFH ISTH NHF VWD Guidelines – an international collaboration
The World Federation of Hemophilia (WFH) has joined a collaboration led by the American Society of Hematology (ASH), which also includes the International Society on...
-
Alert on the use of vials of water for injection (2.5ml, 5ml and 10ml) included in some LFB BIOMEDICAMENTS products
Please note that LFB BIOMEDICAMENTS has issued an alert concerning a defect in the quality appearance of the water for injection (vials 2.5ml, 5ml and...
-
From protocols to demo videos: the WFH Laboratory Manual on the eLearning Platform
The World Federation of Hemophilia (WFH) is pleased to showcase the Diagnosis of Hemophilia and Other Bleeding Disorders: A Laboratory Manual, the definitive how-to guide...
-
WFH World Bleeding Disorders Registry kick-off webinar and live training opportunities
On December 12, 2017, the WFH hosted a webinar for people across the globe interested in learning more about participating in the WFH World Bleeding...
-
First case of an anti-drug antibody reported in Hemlibra trial
Roche has reported that a young patient in the HAVEN 2 clinical trial for Hemlibra (emicizumab) has developed an anti-drug antibody to Hemlibra resulting in...
-
Update from Roche on Hemlibra (emicizumab)
Update from Roche on Hemlibra (emicizumab), for more information please click here.
-
Update on Shire and Roche/Genentech patent dispute regarding Hemlibra
Update: On March 28, 2018, Chugai Pharmaceuticals, a subsidiary of Roche, announced that a Japanese court ruled that the hemophilia treatment product Hemlibra (emicizumab) does...
-
New and Updated: The Guide for the Assessment of Clotting Factor Concentrates, 3rd edition
Determining the safety and quality of therapeutic products for the treatment of hemophilia is crucial for the optimal treatment of patients. The World Federation of...
